Literature DB >> 23574132

Factor VIII products and inhibitors in severe hemophilia A.

Alfonso Iorio, Mark W Skinner, Mike Makris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23574132     DOI： 10.1056/NEJMc1301995

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.

Authors:  Peter W Collins; Benedict P Palmer; Elizabeth A Chalmers; Daniel P Hart; Ri Liesner; Savita Rangarajan; Katherine Talks; Michael Williams; Charles R M Hay
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

2.  Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study.

Authors:  Susan Halimeh; Christoph Bidlingmaier; Christine Heller; Sven Gutsche; Susanne Holzhauer; Gili Kenet; Karin Kurnik; Daniela Manner; Alfonso Iorio; Ulrike Nowak-Göttl
Journal:  Biomed Res Int       Date:  2013-10-02       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.